NCT01813448View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Pharmacokinetics of FidaxomicinHealthy Subjects
Interventions
DRUG

Fidaxomicin

oral

DRUG

Placebo

oral

Trial Locations (1)

91206

Parexel, Glendale

All Listed Sponsors
collaborator

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01813448 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter